| Lotronex Information Center | |
|
Lotronex Action Group
Lotronex Action Group News
News and newsletters regarding the push to have Lotronex put back on the market for IBS.
Lotronex Petition
A petition to the FDA asking for continued collaberation with GlaxoSmithKline to "permanently provide access and safe distribution of the drug to those diagnosed with diarrhea-predominant Irritable Bowel Syndrome."
Lotronex Action Group Press
Press releases from the LAG, and other news regarding Lotronex.
News
November 29, 2000
Lotronex pulled from market
After meetings with Food and Drug Administration (FDA), Glaxo Wellcome has made the decision to pull Lotronex (alosetron hydrochloride) from the market.
October 31, 2000
Death Reports Prompt Another FDA Probe Of Lotronex
The Food and Drug Administration (FDA) is reviewing the safety of Lotronex after reports that five women died after using the medication.
August 25, 2000
Tougher Warnings on Lotronex
US officials are now requiring consumer-friendly information about the possible side effects of Lotronex to be distributed. Warnings on the drug are also being strengthened.
FDA Press Releases and Documents
August 24, 2000
FDA Press Release on Lotronex
Official word from the Food and Drug Administration (FDA) abou Lotronex, including excerpts from the Lotronex Medication Guide which is attached to every bottle of the drug.
June 27, 2000
Gastrointestinal Drugs Advisory Committee Meeting
Transcripts, briefing information, and questions for discussion from the Gastrointestinal Drugs Advisory Committee meeting regarding adverse affects to Lotronex.
Questions and Answers
From the FDA, commonly asked questions about Lotronex and the Lotronex Medication Guide.
Glaxo Wellcome Inc. Press Releases and Documents
"Dear Health Care Professional" Letter
Reprinted by the FDA, a letter sent by Glaxo Wellcome Inc. to physicians who prescribe Lotronex.
"Dear Pharmacist" Letter
Reprinted by the FDA, a letter sent by Glaxo Wellcome Inc. to pharmacists regarding Lotronex.
Lotronex Patient Information
PharmInfoNet DrugFAQs: Lotronex (alosetron)
A few questions and answers about Lotronex, including some special warnings and general precautions.
RxList Alosetron (Lotronex®) FAQ
Includes a description, medication interactions, side effects, and warnings for Lotronex.
Reporting Adverse Reactions
How to Report Adverse Reactions & Medical Product Problems to the FDA
"FDA encourages anyone aware of a serious adverse reaction (to Lotronex), including consumers, to make a MedWatch report."
